首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 171 毫秒
1.
肾上腺髓质素抑制内皮素的促血管平滑肌细胞增殖作用   总被引:10,自引:2,他引:10  
李田昌  田青 《高血压杂志》1996,4(3):171-178
目的观察肾上腺髓质素adrenomodulin,AM)对血管平滑肌细胞(VSMC)内丝裂素活化蛋白激酶(mitogen-activatedpro-teinkinase,MAPK)活性和VSMC增殖的作用。方法测定培养的VSMC内MAPK活性和3H-TdR参入。结果10-8ET-1可明显增加培养的VSMCs内3H-TdR参入(增加67%,P<0.01)和APK激活(活性增高11倍,P<0.01),而10-10~10-7mol/L肾上腺髓质素(13-52)[AM(13-52)]与ET-1(10-8mol/L)同时孵育,则可显著抑制ET-1的上述作用,与10-8mol/LET-1单独应用时相比,3H-TdR参入和MAPK活性分别减低22%~52%(P值均<0.01)和8.1~29.4%(P值分别<0.05或0.01)。而单用AM(13-52)对培养的VSMC3H-TdR参入和MAPK活性无明显影响(P值>0.05)。结论AM(13-52)具有抑制ET所致的MAPK激活和VSMC增殖的作用。AM与ET相互作用,参与内皮源的细胞旁分泌调节体系的构成,共同维持循环系统功能的稳态  相似文献   

2.
分析一组高血压病患者血浆和淋巴细胞中血管紧张素Ⅱ(AngⅡ)、内皮素(ET)和一氧化氮(NO)含量的变化及它们间的相互关系。方法高血压(EH)组39例,正常对照(NC)组41例,放射免疫分析法测定AngⅡ、ET,高效液相色谱分析法测定NO。结果EH患者血浆和淋巴细胞中ET均高于NC组(P分别<0.05和<0.01),NO低于NC组(P分别<0.05和<0.01)。除血浆ET和NO外,各指标改变EHⅡ期较Ⅰ期明显(P分别<0.05和<0.01)。逐步回归分析表明,EH组平均动脉压(MAP)与血浆及淋巴细胞中AngⅡ、ET呈正相关,与NO负相关(r分别=0.67,0.81,P均<0.01);EH组血浆和淋巴细胞中NO与AngⅡ、ET均呈负相关(r分别=-0.651,-0.725,P均<0.01)。结论淋巴细胞反映血管内皮细胞内分泌功能比血浆更为敏感,与MAP相关性更好,AngⅡ、ET和NO三者分泌失平衡,是EH发病的重要原因之一。  相似文献   

3.
以培养的自发性高血压大鼠(SHR)和正常对照大鼠(WKY)血管平滑肌细胞(VSMC)为模型,动态观察了精氨酸加压素(AVP)对动脉VSMC的一氧化氮合酶(NOS)活性、一氧化氮(NO)合成的影响。结果表明:SHR动脉VSMC的NOS活性、NO含量明显低于WKY(P<0.05);AVP对SHR动脉VSMC的NOS活性、NO合成具有显著促进效应;同一浓度AVP作用于SHR及WKY动脉VSMC,WKY的NOS活性及NO含量显著高于SHR(P<0.01);AVP作用后,动脉VSMC的NOS活性与NO含量呈显著正相关。提示SHR动脉VSMC的NOS-NO系统可能功能不良;AVP可能通过NOS-NO途径参与高血压病的发生和发展。  相似文献   

4.
本文检测了42例NIDDM病人红细胞变形能力(ED)和红细胞ATP酶活性、红细胞内离子浓度的变化。结果显示NIDDM病人红细胞滤过指数(IF)较对照组明显增高(P<0.001);红细胞Na+-K+-ATP酶和Ca2+-ATP酶活性较对照组明显降低(P<0.01),Mg2+-ATP酶活性变化不明显;红细胞内Na+、Ca2+浓度较对照组明显增高(P<0.01),而Mg2+浓度较对照组明显降低(P<0.01)。有血管病变者这些变化较无血管病变者更明显。NIDDM病人红细胞IF与Na+-K+-ATP酶、Ca2+-ATP酶活性呈负相关(r=-0.468,-0.458,P<0.001),与红细胞内Na+、Ca2+浓度呈正相关(r=-0.473,0.466,P<0.D01),与Mg2+浓度呈负相关(r=-0.436,P<0.01)。  相似文献   

5.
观察了犬冠脉内灌注N-单甲基左旋精氨酸(L-NMMA)后再灌注L-精氨酸(L-Arg)和单独灌注L-NMMA前后冠脉血流动力学、冠脉血流储备以及冠脉对不同浓度的乙酰胆碱(Ach)反应的变化,同时用放免法测定冠脉前降支(LAD)伴行静脉血中内皮素-1(ET-1)含量。结果发现,L-Arg完全逆转了灌注L-NMMA引起的血流动力学改变,使心率回升,下降的基础冠脉流量(CBF),从20±8ml/min回升至28±7ml/min,P<0.05),降低的冠脉储备恢复,从51±10ml/min升至94±15ml/min,P〈0.01),ET-1的含量不再升高,从15.5±3.0ng/L下降至5.0±2.0ng/L,P〈0.01),Ach介导的CBF增加不再受到抑制(P〈0.01)。结果提示提供外源性L-Arg可增加一氧化氮(NO)的产生,使由于NO抑制而产生的血流动力学改变和ET-1升高发生逆转。  相似文献   

6.
目的观察戊酸雌二醇对18月龄雌性老年前期大鼠下丘脑、垂体和血浆内阿片肽含量及下丘脑内阿片肽mRNA水平的影响。方法采用NorthernBlot和神经肽放免测定法。结果与5月龄青年大鼠比较,18月龄大鼠下丘脑和血浆β-内啡肽(β-EP)、亮氨酸脑啡肽(L-ENK)、强啡肽A1-13(DynA1-13)含量明显降低(P<0.05或0.01);垂体β-EP、L-ENK含量升高,DynA1-13含量降低(P<0.01);下丘脑阿黑皮素原(POMC)基因和脑啡肽原(proenkephalin)基因mRNA水平明显低于青年大鼠(P<0.05)。肌注戊酸雌二醇后,老年前期大鼠下丘脑POMC和proenkephalin基因mRNA水平明显升高(P<0.05);下丘脑β-EP含量增加(P<0.05);垂体β-EP降低,L-ENK升高;血浆DynA1-13含量增加(P<0.05)。结论戊酸雌二醇促进老年前期雌性大鼠下丘脑β-EP基因表达,增强其合成能力,而对L-ENK和DynA代谢的影响不明显。  相似文献   

7.
观察了犬冠脉内灌注N-单甲基左旋精氨酸(L-NMMA)后再灌注L-精氨酸(L-Arg)和单独灌注L-NMMA前后冠脉血流动力学、冠脉血流储备以及冠脉对不同浓度的乙酰胆碱(Ach)反应的变化,同时用放免法测定冠脉前降支(LAD)伴行静脉血中内皮素-1(ET-1)含量。结果发现,L-Arg完全逆转了灌注L-NMMA引起的血流动力学改变,使心率回升,下降的基础冠脉流量(CBF),从20±8ml/min回升至28±7ml/min,P<0.05),降低的冠脉储备恢复,从51±10ml/min升至94±15ml/min,P〈0.01),ET-1的含量不再升高,从15.5±3.0ng/L下降至5.0±2.0ng/L,P〈0.01),Ach介导的CBF增加不再受到抑制(P〈0.01)。结果提示提供外源性L-Arg可增加一氧化氮(NO)的产生,使由于NO抑制而产生的血流动力学改变和ET-1升高发生逆转。  相似文献   

8.
应用单克隆与多克隆双抗体夹心法检测36例病毒性心肌炎(VMC)及24例正常人(NC)的血清可溶性白细胞介素2受体(sIL-2R),同时测定外周血自然杀伤细胞(NKC)活性和T淋巴细胞亚群。结果显示VMC患者sIL-2R明显高于NC组(P<0.001).而NKC活性明显低于NC组(P<0.01),T细胞亚群与NC组比较,急性VMC患者总T细胞(CD3),辅助性T细胞(CD4)和抑制性T细胞(CD8)均减少,CD4/CD8比值显著降低(P<0.05.0.01),以细胞免疫功能低下为明显;而VMC后遗症期患者CD3、CD4与NC组无差异(P>0.05),CD8显著降低(P<0.05),CD4/CD8比值显著高于NC组(P<0.05),以细胞免疫调节失衡为主。上述结果提示细胞免疫功能低下及免疫功能失调为VMC发病及影响预后的重要因素。  相似文献   

9.
目的探讨急性和慢性呼吸道炎症过程中激肽的生成途径和机制。方法测定支气管肺癌伴阻塞性肺炎,慢性支气管炎和健康对照组支气管肺泡灌洗液(BALF)凝胶过滤前后激肽、激肽形成酶活性(TAMEea),血浆血管舒缓素(PK)和α2巨球蛋白(α2M),并进一步鉴定TAMEea性质。结果急、慢性组TAMEea和激肽水平与健康对照组比较差异有显著性(P<0001,P<0.01),但两组间差异无显著性(P>005);急性组PK和α2M与慢性组比较差异有显著性(P<0001)。凝胶过滤结果显示:急性组BALF的TAMEea最高峰位于分子量约800000处,与第一个α2M峰重叠,而慢性组的最高峰位于40000处。TAMEea抑制试验证实800000处的TAMEea来自于PK;而40000处的TAMEea主要来源于组织血管舒缓素(TK)。结论急性呼吸道炎症的TAMEea主要来自血浆的PK;而慢性呼吸道炎症则以局部组织腺体分泌的TK为主。  相似文献   

10.
2型糖尿病患者性激素水平与免疫功能关系的探讨   总被引:1,自引:0,他引:1  
目的 了解2型糖尿病(2型DM)患者性激素水平与免疫功能的关系。方法 用放免法测定57例(男31例,女26例)2型糖尿病患者及对照组50例(男24例,女26例)的血清雌二醇(E2),睾酮(T)水平,用乳酸脱氢酶释放法测定自然杀伤细胞活性(NKCA),用计数法测定CD4,CD8的百分比,结果 男、女性2型DM患者的MKCA显著低于对照组(P〈0.01)。女性2型DM组E2/T显著低于对照组(P〈0.  相似文献   

11.
原发性高血压患者血浆一氧化氮,内皮素变化   总被引:15,自引:0,他引:15  
目的探讨原发性高血压患者血浆一氧化氮和其对应缩血管性物质内皮素含量变化及其临床意义。方法60例原发性高血压患者,平均年龄54.5±9.2岁,男性31例,女性29例,接受血浆比色法的硝酸根和放免法内皮素含量测定。结果患者血浆硝酸根含量明显低于正常人,而内皮素含量却明显高于正常人。这种变化和疾病严重程度相平行,而和病程无关。结论血管内皮细胞产生的这一对扩张和收缩血管的因子的失衡在高血压的发病上起重要作用。  相似文献   

12.
牛磺酸对大鼠胰岛素抵抗高血压的影响   总被引:3,自引:0,他引:3  
目的探讨牛磺酸对胰岛素抵抗高血压大鼠的影响。方法在输注胰岛素和葡萄糖引起动物胰岛素抵抗高血压模型上,测量平均动脉压、心率、血糖,放射免疫法测定血浆胰岛素和内皮素及主动脉组织内皮素,用2-脱氧葡萄糖摄取评估骨骼肌葡萄糖转运活性,用乙醇沉淀法测定肌糖原合成,测定肝胰岛素清除。结果胰岛素抵抗高血压大鼠血压升高,心率加快,血糖和血浆胰岛素含量增加(P<0.01)。牛磺酸治疗可明显改善上述指标,并增加骨骼肌葡萄糖转运活性,促进肌糖原合成和肝胰岛素清除,同时减轻血浆和主动脉内皮素含量。结论牛磺酸治疗胰岛素抵抗高血压大鼠是有效的。  相似文献   

13.
Endothelin system-dependent cardiac remodeling in renovascular hypertension   总被引:3,自引:0,他引:3  
The aim of the present study was to analyze whether the cardiac endothelin system contributes to cardiac remodeling in rats with 2-kidney, 1 clip (2K1C) renovascular hypertension. The endothelin system seems to be a promising candidate for cardiac remodeling because endothelin (ET)-1 promotes growth of cardiomyocytes in vitro and induces cardiac collagen synthesis. The activity of the cardiac endothelin system was analyzed by measuring cardiac tissue big ET-1 and ET-1 concentrations as well as by estimating the cardiac expression of the ETA and ETB receptors 10 days, 4 weeks, and 12 weeks after the renal artery was clipped. The effects of long-term treatment with ETA, ETB, and combined ETA/ETB receptor antagonists on cardiac hypertrophy, media/lumen ratio of intracardiac arteries, and left ventricular fibrosis were also analyzed. This study demonstrated that the overall left ventricular cardiac endothelin system has a similar activity in the early, middle, and late stages of 2K1C renovascular hypertension compared with sham-operated controls. Fibrosis of the left ventricle and hypertrophy of intracardiac arteries, however, were markedly altered after long-term treatment with endothelin receptor antagonists in a blood pressure-independent manner. These 2 effects are mediated by different subtypes of endothelin receptors. ETA receptor blockade completely normalized the hypertrophy of intracardiac arteries (P<0. 01 compared with 2K1C without treatment) in renovascular hypertension, whereas the ETB antagonist reduced cardiac fibrosis of the left ventricle (P<0.001 compared with 2K1C without treatment) to baseline values. This study demonstrates that the cardiac endothelin system plays an important role in the development of cardiac fibrosis as well as in hypertrophy of intracardiac arteries in 2K1C renovascular hypertensive rats.  相似文献   

14.
目的 研究原发性高血压患者血一氧化氮(NO)及内皮素(ET)水平的变化与高血压轻重程度、血压节律异常的相关性及其临床意义.方法 高血压组232例,对照组130例.高血压组内分为低危、中危、高危组分别89、78、65例;按血压节律性分为杓型与非杓型组分别109、123例.所有受试者进行NO、ET检测和动态血压分析.结果 高血压组与正常对照组比较血NO降低而ET升高,二者比值下降更明显,在两组间如上三组数据差异均有统计学意义.原发性高血压各组随高血压危险度上升,NO降低,ET升高,二者比值下降的幅度有加大趋势.原发性高血压患者随着正常血压节律性的丧失,NO降低,ET升高,二者比值下降的幅度有加大趋势.结论 血NO上升、ET下降及二者比值的相应明显变化不仅与原发性高血压的发病有关,也与高血压的危险程度和血压正常节律的存在与否具有明显的相关性.  相似文献   

15.
BACKGROUND: To test the hypothesis that endothelin-1 contributes to cardiac fibrosis, cardiac collagen deposition was studied in deoxycorticosterone acetate-salt (DOCA-salt) hypertensive rats, in which the endothelin system is activated. The effects of the ET(A)-selective endothelin receptor antagonist A-127722 were evaluated. METHODS AND RESULTS: A-127722 (30 mg/kg per day) was administered for 4 weeks. Myocardial fibrosis was evaluated after Sirius red F3BA staining. Systolic blood pressure was 103+/-1.6 mm Hg in unilaterally nephrectomized rats (Uni-Nx), 202+/-3.2 mm Hg in DOCA-salt rats (P:<0.01 versus Uni-Nx), and 182+/-3.1 mm Hg in ET(A) antagonist-treated DOCA-salt rats (P:<0.01 versus DOCA-salt or Uni-Nx). In DOCA-salt rats, interstitial and perivascular collagen density was increased in the subendocardial and midmyocardial regions of the left ventricle (3- to 4-fold, P:<0.05), whereas in subepicardial myocardium, the increase was predominantly perivascular. The ET(A) antagonist prevented cardiac fibrosis in DOCA-salt rats. Procollagen I and III mRNA, which were increased in hearts of DOCA-salt rats, were normalized by ET(A) antagonist treatment. TGF-beta(1) mRNA and TGF-beta(1) protein increased at 1 week in DOCA-salt rats and were lowered in ET(A) antagonist-treated rats. CONCLUSIONS: ET(A) receptor-mediated collagen deposition in hearts of DOCA-salt rats results from increased procollagen synthesis associated with an initial increment in expression of TGF-beta(1). These results support the hypothesis of a role for endothelin-1 in cardiac collagen deposition in mineralocorticoid hypertension, which may have pathophysiological and pharmacological implications in hypertensive heart disease.  相似文献   

16.
OBJECTIVES: We investigated if endothelin (ET)-1 and the renin-angiotensin-aldosterone system play a role in cardiac fibrosis. BACKGROUND: Angiotensin II (Ang II) can induce cardiac fibrosis, but the underlying mechanisms are incompletely understood. METHODS: Four-week-old transgenic (mRen2)27 rat (TGRen2) received for four weeks a placebo, the mixed ET(A)/ET(B) endothelin receptor antagonist bosentan, the angiotensin II type I receptor (AT-1) antagonist irbesartan, the ET(A) endothelin receptor antagonist BMS-182874, and a combined treatment with irbesartan plus BMS-182874. We measured collagen density on Sirius red-stained serial sections of the left ventricle (LV) with a photomicroscope equipped with specific software and assessed the gene expression of procollagen alpha1(I), atrial natriuretic peptide (ANP), transforming growth factor-beta 1 (TGFbeta1), endothelin converting enzyme, and ET(B) receptor. RESULTS: In the placebo group, hypertension was associated with LV hypertrophy and cardiac fibrosis (LV weight: 4.0 +/- 0.3 mg/g body weight; collagen density: 2.21 +/- 0.16%), which were all prevented with irbesartan (2.3 +/- 0.1, 1.30 +/- 0.13, p < 0.001), but not with BMS-182874 (4.0 +/- 0.2, 2.41 +/- 0.22). Bosentan also prevented fibrosis (1.39 +/- 0.18) but not hypertension and LV hypertrophy (3.38 +/- 0.27). Combined irbesartan and BMS-182874 treatment prevented LV hypertrophy (2.9 +/- 0.1) but not fibrosis (2.52 +/- 0.16). Collagen density correlated (r = 0.414, p < 0.05) with plasma aldosterone levels. In TGRen2 with LV hypertrophy, the gene expression of ANP and ET(B) but not that of TGFbeta1 and procollagen alpha1(I) was increased. CONCLUSIONS: In Ang II-dependent hypertension, cardiac fibrosis was associated with LV hypertrophy and was hindered by both mixed ET(A)/ET(B) blockade and AT-1 blockade. Only the latter treatment prevented both hypertension and LV hypertrophy. Thus, there is a dissociation between the mechanisms of cardiac fibrosis and hypertension, which do and do not entail ET-1, respectively.  相似文献   

17.
氨氯地平,卡托普利逆转高血压左室肥厚效应的对比   总被引:2,自引:0,他引:2  
氨氯地平、卡托普利逆转高血压左室肥厚效应的对比平庆功1臧梦维2陈■1汪祥海1严文魁1(1.皖南医学院附属医院干内科,芜湖2410012.中国协和医科大学基础医学院药理教研室,北京100005)TheRegressionEfectofAmlodipin...  相似文献   

18.
新近研究表明丝裂素活化蛋白激酶(MAPK)是细胞增殖肥大的重要酶类,为各种细胞外的生长刺激信号引起细胞内信息传递的共同通路或汇聚点。本文通过观察自发性高血压大鼠(SHR)心肌MAPK活性和心肌肥大的关系,探讨SHR心肌肥大发生的可能细胞内信息传递机制。方法:4个月的SHR和WKY大鼠各8只,以心重/体重的比值表示心肌肥厚的程度,采用胶内磷酸化法测定心肌MAPK活性。结果:与WKY大鼠比较,SHR心肌MAPK活性增加107.0%(P<0.01),心肌肥大程度增加38.3%(P<0.01)。心肌MAPK活性与心肌肥大程度呈显著正相关(r=0.708,P<0.05)。结论:SHR心肌肥厚可能涉及MAPK。  相似文献   

19.
目的 探讨预处理对肝脏缺血再灌注损伤大鼠肝组织和血液中一氧化氮 (NO)和内皮素 (ET)含量的影响及意义。方法 建立肝脏 70 %缺血再灌注损伤大鼠模型 ,分为对照组、缺血组、缺血预处理组、L -精氨酸组(L - arg)、Nω-硝基 - N -精氨酸甲酯 (L - NAME)组 ,观察各组肝功能变化 ,检测肝组织和血清中 NO和 ET及透明质酸 (HA)水平。结果 预处理可减轻 NO水平的下降和血浆 ET的升高 ,防止肝功酶的升高 (P<0 .0 5 )。结论 预处理可诱导缺血再灌注损伤大鼠 NO产生增加、ET产生减少 ,进而改善其微循环 ,减少再灌注损伤。  相似文献   

20.
目的 了解高血压心脏病左室结构、功能变化时血浆及心肌组织中心钠素(atrial natriuretic peptide ANP)、内皮素(endothelin ET)含量变化。方法 应用放免法监测二肾一夹意义型(2K1C)肾血管性高血压大鼠(RHR)血浆及心肌组织中ANP、ET含量变化,并根据超声心动图评价高血压大鼠心脏结构、功能动态变化,将高血压大鼠进行分组。结果 高血压左室向心性肥厚期血浆及心肌组织(左心室)中ANP、ET含量明显升高;左室离心性肥厚期血浆ET较向心性肥厚期组更高,但心肌组织中ET含量与其无显著差别,而血浆及心肌组织中.ANP含量均较向心性肥厚期组低。结论 2K1C型高血压大鼠血浆及心肌组织中ANP、ET含量均升高;血浆ET与.ANP含量变化在左室肥厚中可能起着更为重要作用。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号